| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
15,907 |
13,311 |
$2.61M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
14,747 |
12,767 |
$1.69M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
6,495 |
5,165 |
$1.41M |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
3,118 |
2,319 |
$1.03M |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,831 |
2,015 |
$539K |
| 71045 |
Radiologic examination, chest; single view |
9,576 |
6,609 |
$295K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
8,882 |
6,824 |
$205K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
5,355 |
4,470 |
$161K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
2,448 |
2,083 |
$161K |
| 80053 |
Comprehensive metabolic panel |
26,960 |
20,654 |
$152K |
| 85027 |
|
28,633 |
22,037 |
$102K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,153 |
1,781 |
$52K |
| 87428 |
|
2,929 |
2,397 |
$47K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,234 |
1,843 |
$45K |
| 36415 |
Collection of venous blood by venipuncture |
28,764 |
21,856 |
$45K |
| 83880 |
|
3,299 |
2,535 |
$40K |
| 82553 |
|
8,452 |
6,168 |
$37K |
| 80305 |
|
4,522 |
3,667 |
$34K |
| 84512 |
|
8,812 |
6,280 |
$32K |
| 80061 |
Lipid panel |
2,912 |
2,477 |
$28K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
339 |
311 |
$27K |
| 71250 |
|
136 |
101 |
$26K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,077 |
1,735 |
$25K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,383 |
1,848 |
$25K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
361 |
272 |
$25K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,004 |
1,276 |
$24K |
| 82550 |
|
8,658 |
6,287 |
$21K |
| G0378 |
Hospital observation service, per hour |
20 |
12 |
$21K |
| 81025 |
|
2,873 |
2,424 |
$18K |
| 81001 |
|
11,712 |
9,202 |
$17K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
3,363 |
2,771 |
$15K |
| 87430 |
|
1,188 |
968 |
$12K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
687 |
534 |
$12K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,268 |
846 |
$11K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
2,013 |
1,733 |
$11K |
| 87276 |
|
1,004 |
826 |
$10K |
| 83605 |
|
2,179 |
1,689 |
$10K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
535 |
305 |
$10K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
47 |
25 |
$9K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,526 |
1,259 |
$9K |
| 87275 |
|
1,003 |
826 |
$9K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,157 |
1,747 |
$9K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
194 |
185 |
$8K |
| 83690 |
|
2,001 |
1,637 |
$7K |
| 83735 |
|
2,509 |
1,935 |
$6K |
| 84439 |
|
895 |
764 |
$6K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
14 |
13 |
$6K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
479 |
345 |
$5K |
| 85379 |
|
905 |
738 |
$4K |
| 85730 |
|
1,757 |
1,361 |
$4K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,279 |
1,086 |
$3K |
| 82150 |
|
868 |
730 |
$3K |
| 85610 |
|
2,098 |
1,635 |
$3K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
93 |
63 |
$3K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
178 |
165 |
$3K |
| 87040 |
|
714 |
494 |
$3K |
| 81003 |
|
1,930 |
1,587 |
$2K |
| 82607 |
|
246 |
201 |
$2K |
| 87420 |
|
216 |
187 |
$2K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
773 |
673 |
$2K |
| 85007 |
|
1,235 |
972 |
$2K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
378 |
289 |
$2K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
17 |
13 |
$1K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
239 |
201 |
$1K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
285 |
207 |
$1K |
| J3490 |
Unclassified drugs |
764 |
621 |
$1K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
658 |
482 |
$1K |
| 71046 |
Radiologic examination, chest; 2 views |
132 |
124 |
$974.82 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
2,434 |
1,969 |
$771.27 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
25 |
13 |
$723.52 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
535 |
399 |
$611.10 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
121 |
62 |
$581.71 |
| 82962 |
|
396 |
244 |
$576.79 |
| 87186 |
|
113 |
75 |
$464.38 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
157 |
125 |
$461.18 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
185 |
153 |
$372.03 |
| 82043 |
|
102 |
95 |
$312.12 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
77 |
46 |
$269.59 |
| J2704 |
Injection, propofol, 10 mg |
774 |
493 |
$218.14 |
| 83550 |
|
40 |
24 |
$202.96 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
48 |
28 |
$178.42 |
| 83540 |
|
40 |
24 |
$150.25 |
| 82728 |
|
15 |
12 |
$149.93 |
| 73562 |
|
16 |
13 |
$125.86 |
| 87077 |
|
31 |
25 |
$121.20 |
| 73630 |
|
13 |
12 |
$92.52 |
| J2060 |
Injection, lorazepam, 2 mg |
37 |
27 |
$73.72 |
| 84100 |
|
18 |
18 |
$56.88 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
15 |
13 |
$34.43 |
| 85652 |
|
17 |
13 |
$24.90 |
| A9270 |
Non-covered item or service |
295 |
175 |
$0.00 |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
1,056 |
113 |
$0.00 |